Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress
- PMID: 15381051
- DOI: 10.1016/j.ejphar.2004.06.069
Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress
Abstract
The effect that chronic unpredictable stress had on the anxiety-like response elicited by the cannabinoid receptor agonist HU-210 [3-(1,1-dimethylheptyl)-(-)-11-hydroxy-delta 8-tetrahydrocannabinol] in the elevated plus maze was investigated here. Male Long-Evans rats were either unstressed or were subjected to a 21-day regimen of chronic unpredictable stress, and subsequently were subdivided into three testing groups (vehicle, 10 and 50 microg/kg of HU-210) and tested on the elevated plus maze. Results demonstrated that in unstressed animals, a low dose of HU-210 induced an anxiolytic response, whereas a high dose induced an anxiogenic response. Further, in stressed animals both the low and the high doses of HU-210 induced anxiogenic responses. These findings suggest that chronic stress enhances either cannabinoid receptor responsivity or one of the interacting systems implicated in emotional states.
Similar articles
-
Cannabinoids & Stress: impact of HU-210 on behavioral tests of anxiety in acutely stressed mice.Behav Brain Res. 2015 May 1;284:225-30. doi: 10.1016/j.bbr.2015.02.025. Epub 2015 Feb 20. Behav Brain Res. 2015. PMID: 25707713
-
Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure.Psychoneuroendocrinology. 2006 May;31(4):526-36. doi: 10.1016/j.psyneuen.2005.11.010. Epub 2006 Jan 27. Psychoneuroendocrinology. 2006. PMID: 16442741
-
The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress.Pharmacol Res. 2000 Jan;41(1):47-53. doi: 10.1006/phrs.1999.0560. Pharmacol Res. 2000. PMID: 10600269
-
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.J Pharmacol Exp Ther. 1996 Jan;276(1):56-64. J Pharmacol Exp Ther. 1996. PMID: 8558457
-
Effects of Δ9-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis.Cannabis Cannabinoid Res. 2023 Feb;8(1):24-33. doi: 10.1089/can.2022.0078. Epub 2022 Aug 17. Cannabis Cannabinoid Res. 2023. PMID: 35984927 Review.
Cited by
-
Endocannabinoid system and synaptic plasticity: implications for emotional responses.Neural Plast. 2007;2007:52908. doi: 10.1155/2007/52908. Neural Plast. 2007. PMID: 17641734 Free PMC article. Review.
-
Endocannabinoid System Components as Potential Biomarkers in Psychiatry.Front Psychiatry. 2020 Apr 27;11:315. doi: 10.3389/fpsyt.2020.00315. eCollection 2020. Front Psychiatry. 2020. PMID: 32395111 Free PMC article. Review.
-
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain.Front Pharmacol. 2014 Feb 6;5:10. doi: 10.3389/fphar.2014.00010. eCollection 2014. Front Pharmacol. 2014. PMID: 24567721 Free PMC article.
-
Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.J Neurochem. 2008 Sep;106(6):2322-36. doi: 10.1111/j.1471-4159.2008.05567.x. Epub 2008 Jul 15. J Neurochem. 2008. PMID: 18643796 Free PMC article.
-
Synaptic neurotransmission depression in ventral tegmental dopamine neurons and cannabinoid-associated addictive learning.PLoS One. 2010 Dec 20;5(12):e15634. doi: 10.1371/journal.pone.0015634. PLoS One. 2010. PMID: 21187978 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical